insightus (pronounced "incite us") harnesses the 21st Century technology of data science to promote a just, civil, democratic and sustainable world. It does this by discovering societal challenges hinted at in large data sets, effectively communicating these newly discovered issues to the public, and collaborating with other highly effective action-oriented non-profits to press for legal and other solutions — a three-part process we term data-driven activism.
Legal Stuffinsightus is a North Carolina non-profit 501(c)(3) corporation, organized in October of 2015. Your donations to insightus are tax deductible).
Board of Directors
William Busa, Ph.D.
Bill is an independent consultant to the biotechnology industry. Previous to that he led several entrepreneurial ventures in that industry, where among other responsibilities he built, led, and managed numerous bioinformatics teams.
Prior to his career in industry, Bill was a professor of biology and biophysics at The Johns Hopkins University. He is an elected fellow of the American Association for the Advancement of Science (AAAS), which in 1998 he assisted in the technical development and launch of the first exclusively online major biomedical journal, Science Signaling.
Mr. Coelho is an engineer/inventor and serial entrepreneur, and the recipient of more than 30 patents in the fields of biomedical tools and devices.
As a concerned citizen, Mr. Coelho was instrumental in bipartisan efforts to enact the Stem Cell Therapeutic and Research Act of 2005 (passed unanimously by Congress and signed by President Bush), authorizing and funding the assembly of a nationwide inventory of 150,000 units of life-saving cord blood stem cells and an information system enabling transplant physicians across America to quickly access the best such units to treat patients suffering blood cancers, immunodeficiencies, and inborn errors of metabolism.
Currently Mr. Coelho serves as CTO and is a co-founder of SynGen Inc., developing cell processing tools to advance the clinical use of stem and immune cells.
Elaine McVey, M.Stat.
Elaine is a professional data scientist and statistician with experience across multiple domains and industries. She has led efforts to use data science to revolutionize decision-making capabilities in both the medical and transit technology industries. Earlier in her career, she specialized in the statistically rigorous development and evaluation of medical technology from initial research through clinical feasibility trials, with a particular focus on diabetes. She is passionate about mentoring young data scientists and about designing effective processes and tools for data analysis.
Elaine is an enthusiastic resident of Durham, North Carolina, where she lives with her two sons and her husband, the owner of an engineering firm.